Merck receives 2016 ENERGY STAR Sustained Excellence Award From US Environmental Protection Agency
Company receives EPA honor for 11th consecutive year.
Merck (MSD) has received an ENERGY STAR 2016 Partner of the Year — Sustained Excellence Award from the US Environmental Protection Agency (EPA) for its continued improvement of energy performance and leadership in energy management in both the pharmaceutical and industrial sectors.
Merck has been an ENERGY STAR partner since 1995 and recognized by the EPA for 11 consecutive years, two times as Partner of the Year and now a ninth time for Sustained Excellence.
“Merck is proud of our partnership with ENERGY STAR, because it helps us promote our energy program and provides guidance to use energy more efficiently,” said Don Watson, vice president, Global Workplace & Enterprise Services, Merck. “We are committed to the efficient use of our natural resources and reducing the environmental impact of our operations.”
The award recognizes one Merck manufacturing site that has achieved ENERGY STAR rankings in the top 25% of pharmaceutical plant energy performance nationwide: Las Piedras, Puerto Rico.
Also achieving certification this year were office buildings in Cokesbury and Branchburg, NJ, as well as an office building in Upper Gwynedd, Pa.
“By continued collaboration with ENERGY STAR, Merck is helping Americans save money, save energy, and do their part to reduce our nation’s greenhouse gas emissions that exacerbate climate change,” said EPA Administrator Gina McCarthy. “I’m proud to recognize Merck with the highest form of ENERGY STAR recognition, as the winner of the 2016 Partner of the Year — Sustained Excellence Award. Merck demonstrates a strong commitment to energy efficiency and to preserving a healthy planet for future generations.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance